Medical Oncologist
Hyderabad's Dedicated Skin Cancer Network · NCCN protocols · 11 city centres + 35 partner centres
Best Skin Cancer Hospital in Hyderabad — 11 Centres, NCCN Protocols, NABH-Accredited Partners
Choosing a skin cancer hospital isn't about picking a building — it's about choosing the team, the protocols, and the infrastructure that will guide your treatment from biopsy to immunotherapy. CION runs Hyderabad's dedicated skin cancer network: 11 city centres, NCCN-protocol care for BCC, SCC, and melanoma, and NABH-accredited surgical partners for Mohs micrographic surgery and plastic reconstruction.
- 45-min consultation — with a senior medical or surgical oncologist
- Tumour-board review — written treatment plan, yours to keep
- NABH-accredited Mohs partners — for high-risk facial BCC & SCC
- Day-care immunotherapy — at all 11 city centres, close to home
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The CION Skin Cancer Panel
17+ senior cancer specialists. One team for your skin cancer case.
Trained at AIIMS, Tata Memorial, and leading international centres. Every skin cancer case is reviewed by 3+ of them — together, in tumour board, with a written plan you can keep.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Did you know?
For high-risk facial basal-cell and squamous-cell skin cancers, Mohs micrographic surgery achieves 5-year cure rates of approximately 99% for primary tumours and 94% for recurrent tumours — significantly higher than the 90–95% reported for standard wide local excision — because every margin is examined under the microscope before the patient leaves the operating room. For melanoma, an experienced dermatopathologist's read of Breslow thickness, mitotic rate, and ulceration determines staging, sentinel-lymph-node-biopsy indication, and adjuvant therapy choice. Choosing a hospital with NABH-accredited Mohs partners and dedicated skin-cancer pathology reads is one of the highest-leverage decisions you will make in skin cancer care.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Why the hospital you choose decides everything
Why the hospital matters more than the building
Most patients begin by searching for the best skin cancer doctor in Hyderabad. The doctor matters — but the doctor works inside a system. A skilled surgeon in a hospital without a pathologist experienced in reading melanoma slides cannot stage your tumour accurately — Breslow thickness, mitotic rate, and ulceration determine everything downstream. A medical oncologist prescribing immunotherapy in a centre without a day-care infusion bay forces you to travel hours for every cycle. A pathology lab that doesn't run BRAF V600 testing delays the decision on whether you qualify for targeted therapy. The institutional pieces around the doctor decide whether good intentions become good outcomes.
This page gives you an honest framework — eight institutional signals that separate hospitals that can manage skin cancer well from hospitals that simply offer the service — and explains how CION is built around them. Use the framework on every hospital you shortlist. If a hospital can't answer in writing, it should fall off your list.
The 8-Point Hospital Decision Framework
8 things that make a hospital genuinely the best for skin cancer in Hyderabad
These are the eight institutional signals oncology audit teams use. Each is verifiable. Each is non-negotiable. Ask the question, get it in writing, and walk away if you can't. Click any card to expand.
A multidisciplinary team with experienced skin-cancer pathology
Skin cancer is surgery + (for melanoma and advanced SCC) systemic therapy + (sometimes) radiation, with reconstruction decisions woven through. The team needs a surgical oncologist or plastic surgeon trained in cutaneous oncology, a medical oncologist running immunotherapy and BRAF/MEK regimens, a radiation oncologist, and a histopathologist who reads skin biopsies regularly. Breslow thickness, mitotic rate, ulceration, and microsatellites need experienced eyes. Ask for named team credentials in writing.
Walk away if the pathology report doesn't routinely include Breslow thickness, mitotic rate, and ulceration.Tumour-board review on every case, before any decision
A skin cancer tumour board reviews biopsy slides, dermoscopy images, staging scans, and BRAF/molecular results together — surgical, medical, radiation oncology, pathology, and (for facial lesions) plastic surgery in one room — and issues a written, agreed treatment plan. It forces dissent on resection margins, sentinel lymph node biopsy indications, and adjuvant systemic therapy.
Walk away if surgery is scheduled in the first consultation without a documented tumour-board review.Annual melanoma and skin cancer surgical volume — in writing
Hospital volume predicts skin cancer outcomes — particularly for melanoma, where sentinel lymph node biopsy technique, wide-local-excision margin judgement, and reconstruction planning all build with case rhythm. Ask: "How many wide local excisions and sentinel lymph node biopsies did your team perform last year? How many Mohs cases were coordinated? What proportion of melanomas were stage I at diagnosis?" Specific numbers indicate transparency.
Walk away if volume is described as "many" — no specific number offered.Dermoscopy, biopsy, and BRAF molecular testing infrastructure
Skin cancer staging needs dermoscopy and a properly performed biopsy (excisional preferred for suspected melanoma; punch or shave for BCC/SCC where appropriate), followed by full pathology — Breslow thickness, Clark level (where reported), mitotic rate, ulceration, and lymphovascular invasion. For advanced melanoma, BRAF V600, NRAS, c-KIT, and PD-L1 testing drive systemic therapy choice. BRAF V600 status determines whether dabrafenib + trametinib or encorafenib + binimetinib are options.
Walk away if BRAF turnaround is more than three weeks — adjuvant decisions depend on it.Day-care immunotherapy close to home
Advanced melanoma is managed with checkpoint inhibitors — pembrolizumab or nivolumab every 3 to 6 weeks, ipilimumab in combination protocols, cemiplimab for advanced cutaneous SCC, and adjuvant immunotherapy for resected stage III/IV melanoma running 12 months. Each infusion is 30 to 90 minutes plus pre-medication and observation, with immune-related adverse event protocols that require oncologist supervision. Ask: "Where can I get my immunotherapy cycles near home?"
Walk away if all immunotherapy is administered at one campus only.NABH-accredited partners for Mohs surgery and plastic reconstruction
Not every skin cancer needs Mohs micrographic surgery or plastic reconstruction — but when a facial BCC or SCC sits near the eyelid, nose, or lip, Mohs offers the highest cure rate with the smallest defect, and reconstruction by a trained plastic surgeon protects function and appearance. NABH-accredited partners signal audited surgical safety.
Walk away if the hospital says "we'll refer you out if needed" but cannot name the Mohs surgeon, plastic surgeon, or partner hospital.Insurance, ArogyaSri, and TPA empanelment in writing
Skin cancer treatment runs from a small outpatient excision to many months of immunotherapy — and the financial profile varies dramatically with stage. A hospital that isn't empanelled for your insurance or ArogyaSri at the specific centre where your surgery happens can derail planning at the worst moment. Pre-authorisation and TPA approvals must be confirmed in writing before treatment begins.
Walk away if cost estimates change after admission — a serious hospital writes them down beforehand.Continuity of care and accessibility
Skin cancer surveillance continues for at least five years — for melanoma, lifelong skin checks every 3 to 12 months depending on stage, plus imaging surveillance for high-risk cases. You will see your team frequently. A hospital an hour away makes every dermoscopy check a half-day; a network of centres close to home — same panel, same protocols, shared records — makes continuity sustainable.
Walk away if you're told you must travel to one campus for every surveillance appointment for the next five years.
Hospital archetype comparison
Cancer-specialty network vs multi-specialty hospital vs Ayurveda — which is structurally right for skin cancer?
Hyderabad has all three models. They are not interchangeable. The right one depends on your tumour type, stage, and whether you need significant facial reconstruction. Here's an honest comparison.
| Hospital archetype | Strengths for skin cancer | Trade-offs | Best fit for |
|---|---|---|---|
| Dedicated cancer-specialty hospital or network | Tumour-board review with experienced pathology reads. Day-care immunotherapy infrastructure. Tight medical-surgical-radiation oncology coordination. Faster BRAF testing turnaround. | Mohs micrographic surgery and complex plastic reconstruction typically coordinated through partners. Strong networks solve this with NABH-accredited tie-ups. | Most skin cancer patients — BCC, SCC, and melanoma at all stages where multidisciplinary oncology and immunotherapy continuity matter. |
| Multi-specialty general hospital | In-house plastic surgery, ENT, ophthalmology — useful for facial reconstruction in one campus. Cardiology and other specialities available during complex surgery. | Oncology competes with other departments for OT bandwidth. Pathology experience with skin biopsies varies. Immunotherapy day-care may not be oncology-dedicated. | Patients with significant comorbidities or where extensive facial reconstruction (multi-stage flap surgery) is the dominant clinical need. |
| Ayurveda hospital | Symptom palliation and post-treatment recovery support. Some patients value the holistic framing. | Not evidence-based as primary curative treatment. Should never delay surgical excision, immunotherapy, or targeted therapy in skin cancer — particularly melanoma. | Strictly as an add-on to allopathic oncology care. Discuss any Ayurveda use openly with your medical oncologist to avoid interactions with checkpoint inhibitors. |
The structurally correct default for most skin cancer patients is a dedicated cancer-specialty hospital or network with NABH-accredited Mohs and plastic-reconstruction partners. This combines tight oncology workflows with safe escalation paths when complex surgery is needed — which is precisely how CION is built.
Why CION — institutional answer
How CION is built for skin cancer at an institutional level
CION is not a single hospital. It is a dedicated cancer-specialty network — 11 centres across Hyderabad and 35+ partner centres across Telangana and Andhra Pradesh — with the same panel of oncologists, the same NCCN protocols, and the same tumour-board governance at every site. The network is architected specifically around the eight signals above.
A network architecture, not a building
Dermoscopy, punch biopsy, day-care immunotherapy, and surveillance skin checks happen at the centre nearest your home. Wide local excisions and sentinel lymph node biopsies run from the surgical pathway. Mohs micrographic surgery and plastic reconstruction are coordinated through NABH-accredited partners. Same panel, same protocols, same records at every site.
Pathology and molecular workup
Every CION skin cancer case gets the full pathology workup NCCN recommends: Breslow thickness, mitotic rate, ulceration, lymphovascular invasion, and — for advanced melanoma — BRAF V600, NRAS, c-KIT, and PD-L1 testing through integrated lab pathways. BRAF V600-mutant melanomas are identified for dabrafenib + trametinib or encorafenib + binimetinib eligibility. Molecular guidance is the standard of care in 2026.
NCCN-protocol systemic therapy at every centre
All 11 CION centres in Hyderabad have day-care immunotherapy bays. Pembrolizumab, nivolumab, ipilimumab, cemiplimab, and BRAF + MEK targeted therapy regimens are administered close to home — not on a single campus an hour away. Oncology-trained nursing, immune-related adverse event protocols, and on-site oncologist supervision are standard at every centre.
NABH-accredited partner network for Mohs & reconstruction
Where a skin cancer case requires Mohs micrographic surgery — typical for high-risk facial BCC or SCC — or significant plastic reconstruction for nasal, periorbital, or auricular defects, CION coordinates the procedure through NABH-accredited partner hospitals with trained Mohs surgeons and reconstructive specialists. You get specialist surgical capability without leaving the CION pathway.
Surveillance, supportive oncology & adverse-event management
Lifetime skin check surveillance for melanoma survivors (every 3 to 6 months for the first two years, then 6-monthly to annually), imaging surveillance for high-risk cases, dedicated nursing for immune-related adverse events (colitis, pneumonitis, endocrinopathies), and psycho-oncology support — all supported within the CION network. These are not afterthoughts; they decide whether recovery is uncomplicated.
Tumour-board governance on every skin cancer case
Every skin cancer case at CION is reviewed by the multidisciplinary tumour board before the treatment plan is finalised. The board debates the staging, the resection margin (1 cm vs 2 cm depending on Breslow thickness), the sentinel lymph node biopsy indication, the adjuvant therapy choice, and the surveillance schedule — and produces a written summary that becomes part of your records, yours to keep.
Did you know? BRAF V600 status drives the entire melanoma drug pathway.
BRAF V600 mutation status determines whether a melanoma patient is eligible for dabrafenib + trametinib or encorafenib + binimetinib — and turnaround under 3 weeks is what makes adjuvant therapy decisions possible. Hospitals without an integrated molecular pathway force you to choose between delay and guesswork.
Network proof — outcomes & credentials
CION's institutional numbers — verifiable, not adjectival
Specifics beat vague claims. Here is the verifiable network footprint behind CION's skin cancer pathway.
| Network metric | CION figure |
|---|---|
| City centres in Hyderabad | 11 |
| Partner centres across Telangana & Andhra Pradesh | 35+ |
| Centres with CT, MRI & PET-CT diagnostics | 6 |
| Day-care immunotherapy bays | All 11 city centres |
| Cancer specialists on panel | 17+ |
| Patients treated network-wide | 15,000+ |
| Skin cancer cases managed annually | 1,000+ per year |
| Google review rating | 4.8★ (800+ reviews) |
| Mohs & plastic-reconstruction partner accreditation | NABH-accredited |
| Tumour-board review on every case | Yes — written summary |
| Written second opinion | Free (worth ₹950) |
| Insurance & ArogyaSri accepted | Yes — empanelled |
| EMI facility for self-paying patients | Selected packages |
Financial accessibility
Insurance, ArogyaSri, and cost transparency
Skin cancer treatment ranges from a single outpatient excision to many months of immunotherapy. Financial clarity at the start is part of clinical care, not separate from it. CION provides a written, itemised treatment plan and cost estimate before any decision is finalised.
ArogyaSri empanelment
Eligible patients can access state-scheme coverage at empanelled CION centres. The CION ArogyaSri coordinator handles paperwork directly.
Cashless insurance
Most major insurers and TPAs are accepted, with pre-authorisation handled by the CION insurance desk before treatment begins.
EMI facility
Available for self-paying patients on selected treatment packages — ask the coordinator during your consultation to see what fits your plan.
Written cost estimate
Surgery, immunotherapy, targeted therapy, and supportive care are itemised in writing before treatment begins — no surprises after admission.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Frequently Asked Questions About Choosing a Skin Cancer Hospital in Hyderabad
Which is the best skin cancer hospital in Hyderabad?
No single hospital is automatically best — the right answer depends on whether you have BCC, SCC, or melanoma, your stage, and where you live. Look for a multidisciplinary team with experienced skin-cancer pathology reads, NCCN protocols, BRAF mutation testing, Mohs surgery access through NABH-accredited partners, sentinel lymph node biopsy infrastructure, and immunotherapy day-care. CION Cancer Clinics meets these criteria with 11 centres across Hyderabad and 1,000+ skin cancer cases managed every year.
How do I choose the right skin cancer hospital in Hyderabad?
Verify eight signals in writing: cancer-dedicated multidisciplinary team with experienced skin-cancer pathology reads, tumour-board review on every case, annual melanoma case volume, in-house or in-network dermoscopy and biopsy services, day-care immunotherapy capacity near home, NABH-accredited partners for Mohs surgery and plastic reconstruction, insurance and ArogyaSri empanelment, and follow-up accessibility. If a hospital can't answer clearly on each, drop it from your shortlist.
What is the success rate of skin cancer treatment in Hyderabad?
Outcomes depend on type and stage. BCC and SCC, when detected early, are almost always curable with surgery. Per US National Cancer Institute SEER data for melanoma: 5-year relative survival is approximately 99% for localised disease, 74% for regional spread, and 35% for distant metastasis. Early detection — particularly while Breslow thickness is under 1 mm — is the single most powerful predictor of survival. See our skin cancer overview for staging detail.
How much does skin cancer treatment cost in Hyderabad?
Costs vary by type, stage, and treatment plan. Indicative ranges: wide local excision ₹30,000–1 lakh; Mohs micrographic surgery ₹50,000–2 lakh (via partner pathway); sentinel lymph node biopsy ₹80,000–2 lakh; BRAF + MEK targeted therapy ₹1–2 lakh per month; immunotherapy ₹1.5–2.5 lakh per cycle. CION provides a written treatment plan and itemised cost estimate before treatment begins, with an EMI facility available for self-paying patients on selected packages.
Should I choose a cancer-specialty hospital or a multi-specialty hospital for skin cancer?
A cancer-specialty hospital or network usually offers tighter oncology workflows — tumour-board review, experienced skin-cancer pathology reads, oncology-trained nursing for immunotherapy, and faster access to medical, surgical, and radiation oncology. A multi-specialty general hospital is the better fit when significant comorbidities (cardiac, renal, hepatic) require in-house cross-speciality support, or when extensive multi-stage facial reconstruction is the dominant need. For most skin cancer patients, the cancer-specialty pathway with NABH-accredited Mohs and plastic-reconstruction partners is the structural fit.
Is Mohs micrographic surgery available for skin cancer in Hyderabad?
Yes. Mohs micrographic surgery is available through select centres in Hyderabad. CION coordinates Mohs surgery through NABH-accredited partner hospitals with trained Mohs surgeons, particularly for high-risk facial BCC and SCC where tissue-sparing matters. Mohs offers the highest cure rates and the smallest functional or cosmetic defect when the tumour location demands it.
Is immunotherapy available for melanoma in Hyderabad?
Yes. Pembrolizumab, nivolumab, and ipilimumab for advanced melanoma — and cemiplimab for advanced cutaneous SCC — are routinely administered in Hyderabad at qualified centres. CION administers immunotherapy at its day-care infusion bays across the network, with on-site oncologist supervision and immune-related adverse event protocols in place. BRAF V600 mutation status is tested before therapy selection to determine whether targeted therapy is an alternative or sequential option.
Do skin cancer hospitals in Hyderabad accept ArogyaSri and private insurance?
Many qualified hospitals are empanelled for ArogyaSri and most major cashless insurers — but empanelment varies by centre. CION Cancer Clinics is empanelled for ArogyaSri and accepts most major cashless insurance providers and TPAs. Request a written cost estimate and confirm pre-authorisation before treatment begins.
Are skin cancer hospitals in Hyderabad NABH accredited?
Several Hyderabad hospitals hold NABH accreditation — the Indian healthcare quality standard covering patient safety, infection control, and clinical governance. CION's partner hospitals for complex surgical pathways (Mohs micrographic surgery, plastic reconstruction, sentinel lymph node biopsy) are NABH-accredited, giving patients audited assurance on infection control and surgical safety.
What facilities should I check before admitting for skin cancer surgery?
Confirm in writing: dedicated oncology OT, pathology turnaround for skin biopsy reads (especially for melanoma), sentinel lymph node biopsy infrastructure (lymphoscintigraphy or blue dye), plastic and reconstructive surgery access for large facial defects, in-house or networked immunotherapy day-care, NABH accreditation of the Mohs partner, room categories, and your surgeon's annual melanoma case volume. Ask for an itemised cost estimate and a clear escalation pathway.
Your skin cancer treatment plan starts with one call
Bring your existing slides and reports — we'll review them, run a tumour board, and give you a written second opinion. Yours to keep.
The information on this page is provided for general educational purposes and reflects current clinical practice in skin cancer oncology at the time of last medical review. It is not a substitute for individual medical advice, diagnosis, or treatment. Treatment decisions, drug choices, dosing, surgical approach, and follow-up schedules must be made by a qualified physician evaluating the specific patient. Survival statistics cited are population-level estimates drawn from public registries and do not predict outcomes for an individual case. Always discuss your specific situation with a qualified medical or surgical oncologist before acting on any information presented here. | Last Medically Reviewed: May 2026 by Dr. Muralidhar Muddusetty — Surgical Oncologist, MBBS (AIIMS), MS Surgery (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh).